Design
Editorial
Answers are grounded in this paper and cite their sources.
The editorial highlights that vaccine-derived polioviruses can emerge in any community with insufficient oral polio vaccine coverage, suggesting the term 'rare' may be misleading.
The live attenuated oral polio vaccine (OPV) was licensed in the United States in 1961 with the knowledge that none of the 3 attenuated poliovirus types were entirely without neurovirulence in test monkeys, all showed mutations toward increased virus virulence in some vaccine recipients, and all spread readily to naive contacts. Mutation concerns were lessened by reports that “progressive” virulence was not found in (limited) field experience [1]. Greater debate focused on the spread of the vaccine viruses, which was viewed by many researchers as the expansion of the number of persons immunized [2] and by others as the infection of nonconsenting persons with OPV progeny virus that was probably mutated, untested for safety, and, thus, unlicensed for use in the general population [3]. The theoretical risks of OPV at the time of licensing were minimal compared with the enormous potential benefits of a vaccine that stimulated immunity similar to natural infection, cost little, and offered hopes for global poliomyelitis control The 1976 report of a special World Health Organization collaborative study described OPV as “among the safest vaccines in use today,” with risk of vaccine-associated paralytic poliomyelitis later placed between 1 case per 2.4 and 1 case per 3.3 million doses of OPV distributed [4]. However, the nature of virus isolates from vaccinees or their contacts who developed poliomyelitis remained unresolved. At the time, the monkey virulence test was the “only test that can truly distinguish between virulent and attenuated strains” [3], but it could not distinguish whether a virulent strain was vaccine derived. Field evidence of OPV progeny reversion to characteristic wild poliovirus transmissibility and virulence remained elusive for nearly 40 years [5] The global Polio Eradication Initiative (PEI) began in 1988. Technological advances began to converge in the mid-1990s that greatly expanded knowledge of vaccine-derived polioviruses (VDPVs). Among these were the capacity for real-time genomic sequencing of poliovirus isolates, recognition that the rate of poliovirus genomic evolution is consistently high (∼1% per year), and the increasing use of automatic sequencers within the global Polio Lab Network. It thus became possible to identify VDPVs on a global scale, first by using antigenic [6] or molecular [7] methods to screen Sabin-strain poliovirus isolates from persons with acute flaccid paralysis (AFP), and sequencing the VP1 regions of all isolates that yield atypical results in the routine assays [8]. The growing success of the PEI and the absence of wild poliovirus in many parts of the world made the recognition of VDPVs easier. By contrast, the success of the PEI in many developing countries fundamentally altered the ecology of poliovirus by eliminating the transmission of wild poliovirus and, thus, all natural immunity, thereby providing a more fertile environment for the emergence and circulation of VDPVs in areas with a relaxed national commitment to comprehensive OPV coverage. The first recognized circulating (c) VDPV (type 1) outbreak caused 21 reported cases of poliomyelitis in 2000–2001 on the island of Hispaniola [9]. Retrospective analysis of earlier type 2 virus isolates from Egypt identified 30 cases of AFP associated with a cVDPV strain over the course of a 10-year period from 1983 to 1993 [10]. Other small outbreaks of cVDPV type 1 have been reported in the Philippines [11] and Indonesia (available at: http://w3.whosea.org/en/Section1226.asp), of types 2 and 3 in Madagascar [12], and of type 1 in China [13]. Immunodeficiency-associated VDPV strains have been isolated from nearly 30 immunodeficient patients (3 currently shedding), and ambiguous (a) VDPV strains have been isolated from the environment [14–16] or from persons with no recognized immunodeficiency and no association with an outbreak [17] In this issue of the Journal of Infectious Diseases Liang et al. [13] document the emergence and spread of a type 1 VDPV strain in a remote rural area of Guizhou Province in southwestern China. Guizhou is of particular interest because it had been one of the last reservoirs for the circulation of indigenous wild poliovirus in China before its eradication in 1994 [18], and the risks for the circulation of poliovirus have remained higher there than in most of the country. As the frequency of mass OPV immunization campaigns declined, China has become increasingly reliant on sensitive surveillance to detect any poliovirus circulation. Previous outbreaks of cVDPV infection elsewhere were detected at least 2 years after the administration of the initiating dose of OPV [17], and they were often detected after circulation was widespread. The early detection described by Liang et al. prompted timely high-risk response immunization campaigns with OPV in and around the outbreak area. Intensive postimmunization surveillance in Guizhou and throughout China found no further evidence of the outbreak cVDPV strain The report by Liang et al. [13] contributes important new insights into the risks, frequency, and dynamics of the emergence of cVDPVs. The outbreak occurred in communities quite remote from major population centers or any areas where poliovirus is endemic. Such communities had long been thought to be unlikely sites for reestablished poliovirus circulation, because the risks of exposure to exogenous wild poliovirus were considered to be low. However, as has been clearly demonstrated by Liang et al., cVDPVs can emerge in any community where OPV use continues at insufficient rates of coverage Each cVDPV outbreak has taught its own lesson. From Haiti, we learned that cVDPVs could emerge in populous tropical areas with low OPV coverage and poor sanitation [9]; from Egypt, we learned that widespread circulation of VDPVs could continue for many years [10]; from the Philippines, we learned that cVDPVs could spread by a few chains of transmission to pockets of low vaccine coverage [11]; from Madagascar, we learned that VDPVs could repeatedly emerge in areas of low vaccine coverage [12]; and from Indonesia, we learned that outbreaks of wild poliovirus and cVDPV infection can be simultaneous and overlapping (available at: http://w3.whosea.org/en/Section1226.asp). From China, we now learn that cVDPVs may still emerge in a country with a good national program for immunization and surveillance, that the emergence of cVDPVs does not require extreme risk conditions, and that historic reservoir areas require ongoing attention. The report clearly documents the importance of sustained sensitive AFP and virologic surveillance, coupled with timely outbreak response measures, to the maintenance of a polio-free state in a large country The findings of Liang et al. [13] dispel the misconception that the emergence of cVDPVs requires recombination of a vaccine strain with one of the ubiquitous species C nonpolio enteroviruses. All cVDPV isolates from the earlier outbreaks were recombinants [17], but the findings in the article by Liang et al. suggest that recombination is an indicator of, rather than a prerequisite for, the emergence of cVDPV. The observation that the cVDPV originated from the Sabin type 1 strain, which is generally considered to be the most stable of the 3 OPV strains [17, 19, 20], underscores the challenges inherent in the administration of a highly mutable live virus RNA vaccine by its natural route of infection as a means to achieve global polio eradication Reports of cVDPV or aVDPV isolates worldwide are often described as being rare, but the use of this word may convey the wrong message. Mounting evidence suggests that any country using OPV that has populations in which vaccine coverage is insufficient should be alert to the risk of the emergence of VDPV
No takes yet. Share an insight, caveat, or question.
Dowdle et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: